课题基金 / 基金详情

ROLES(S) OF GLYCOSPHINGOLIPIDS IN NEURAL AIDS

ROLES(S) OF GLYCOSPHINGOLIPIDS IN NEURAL AIDS
鞘糖脂在神经艾滋病中的作用
批准号:
6540277
负责人:
Cara-Lynne Schengrund
金额:
$23.16万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-04-01 至 2004-03-31

项目摘要

项目成果

Cara-Lynne Schengrund的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Description (Adapted from Applicant's abstract): Glycospingolipids (GSLs) have been implicated as fusion co-factors for human immunodeficiency virus (HIV) the causative agent of AIDS. The overall goal of the proposed research is to determine the role(s) of GSLs in the interaction of HIV-1-associated gp120 with different cell types of the central nervous system (CNS) or models thereof, and to use that information to develop possible inhibitors of that interaction. Emphasis is placed on CNS cells or possible models thereof because many individuals infected with HIV-1 eventually develop HIV-1-associated dementia (HAD) in the absence of opportunistic infection. The specific aims of this proposal are to: 1) identify which GSL(s) is/are the ligand(s) for HIV-1-associated gp120. Experiments will be done to confirm that GSLs are necessary for HIV-1 entry and, in those instances where they are necessary, the GSLs adhered to by HIV-1 will be identified. 2) determine the contribution of the GSL saccharide and ceramide moieties to interactions with HIV-1-associated gp120. Experiments will be carried out to determine whether the saccharide portion of each GSL adhered to by HIV-1 can inhibit HIV-1 adherence to the GSL immobilized on plastic or whether a "multivalent" saccharide or the ceramide portion per se is needed. 3) determine whether the inhibitor of HIV-1 associated gp120-mediated adherence to a GSL is able to inhibit gp120-mediated entry of the virus into cells expressing the GSL. The effectiveness of the inhibitor identified in the 2nd aim at blocking infection will be monitored using microglia and asrtrocytes. The effectiveness of the virus at inducing apoptosis in neuroblastoma cells in the presence and absence of inhibitor will also be ascertained. The results should indicate the portion of the GSL(s) recognized by HIV-1. They may also provide the basis for development of an inhibitor able to block adherence of HIV-1 to its GSL fusion co-factor thereby blocking its entry into the cell.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Glycoconjugates: roles in neural diseases caused by exogenous pathogens.
糖缀合物:在外源病原体引起的神经疾病中的作用。
DOI: 10.2174/187152706777950701
发表时间: 2006
期刊: CNS & neurological disorders drug targets
影响因子: --
作者: [Schengrund,Cara-Lynne]
通讯作者: Schengrund,Cara-Lynne
Can mannosylated dendrimers inhibit HIV-1 infection of DC-SIGN expressing cells
Can mannosylated dendrimers inhibit HIV-1 infection of DC-SIGN expressing cells
ROLES(S) OF GLYCOSPHINGOLIPIDS IN NEURAL AIDS
ROLES(S) OF GLYCOSPHINGOLIPIDS IN NEURAL AIDS